News

Monoceros Biosystems, a leading bioinformatics/computational biology provider, is pleased to announce the appointment of Regan Lohman to its Board of Directors

We are thrilled to announce the appointment of Regan Lohman [...]

By |2024-03-25T16:46:56+00:00March 25th, 2024|News|Comments Off on Monoceros Biosystems, a leading bioinformatics/computational biology provider, is pleased to announce the appointment of Regan Lohman to its Board of Directors

Monoceros Biosystems and SeekIn Join Forces to Pave the Way for Cutting-Edge AI-Powered Cancer Diagnostics

San Diego, September 21, 2023 – Monoceros Biosystems, a prominent [...]

By |2023-09-21T17:29:39+00:00September 21st, 2023|News|Comments Off on Monoceros Biosystems and SeekIn Join Forces to Pave the Way for Cutting-Edge AI-Powered Cancer Diagnostics

MRTX1719 is an MTA-cooperative PRMT5 inhibitor that exhibits synthetic lethality in preclinical models and patients with MTAP deleted cancer

Mirati Therapeutics, in collaboration with Monoceros Biosystems and leading academic [...]

By |2023-09-11T20:43:00+00:00August 8th, 2023|News|Comments Off on MRTX1719 is an MTA-cooperative PRMT5 inhibitor that exhibits synthetic lethality in preclinical models and patients with MTAP deleted cancer

Anti-tumor efficacy of a potent and selective non-covalent KRASG12D inhibitor

Mirati Therapeutics, in collaboration with Array BioPharma (Pfizer) and Monoceros [...]

By |2022-10-19T17:45:12+00:00October 10th, 2022|News|Comments Off on Anti-tumor efficacy of a potent and selective non-covalent KRASG12D inhibitor

Monoceros Biosystems Recognized on Inc. 5000 List of Fastest-Growing Private Companies in America

By |2022-08-22T15:21:57+00:00August 19th, 2022|News|Comments Off on Monoceros Biosystems Recognized on Inc. 5000 List of Fastest-Growing Private Companies in America

Monoceros Biosystems has been selected as a top 10 bioinformatics solution provider for 2020 by the CIO Applications magazine

By |2022-08-10T03:59:37+00:00August 18th, 2020|News|Comments Off on Monoceros Biosystems has been selected as a top 10 bioinformatics solution provider for 2020 by the CIO Applications magazine

The KRASG12C Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients

Mirati Therapeutics, in collaboration with additional groups including Monoceros Biosystems, [...]

By |2022-08-10T04:00:42+00:00January 1st, 2020|News|Comments Off on The KRASG12C Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients

Monoceros Biosystems: Bringing Professional Grade Bioinformatics to All

Monoceros Biosystems has been selected as a top 10 bioinformatics [...]

By |2022-08-10T04:00:12+00:00September 25th, 2019|News|Comments Off on Monoceros Biosystems: Bringing Professional Grade Bioinformatics to All

Monoceros Biosystems, a top bioinformatics/computational biology industry partner, is pleased to announce the appointment of John Lamb, PhD and Dan Rawlins, JD to its Advisory Board

Monoceros Biosystems LLC is pleased to announce that John Lamb, [...]

By |2022-08-09T23:21:36+00:00September 23rd, 2019|News|Comments Off on Monoceros Biosystems, a top bioinformatics/computational biology industry partner, is pleased to announce the appointment of John Lamb, PhD and Dan Rawlins, JD to its Advisory Board
Go to Top